Sandoz Recalls Alprazolam Tablets Due to Stainless Steel Particulates
Sandoz Incorporated is recalling 1,332 bottles of Alprazolam 0.25mg tablets nationwide because they may contain stainless steel metal particulates.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving potential physical hazards like foreign particulates that could cause injury.
Plain-English summary
Sandoz Incorporated is recalling 1,332 bottles of Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets (NDC 0781-1061-10). The recall is due to the presence of a foreign substance, specifically stainless steel metal particulates, which may be contained in the tablets.
The affected product is distributed nationwide. The specific lot number is EJ9591. This is a Class II recall, indicating a situation in which there is a reasonable probability that the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider for further instructions. Sandoz Incorporated is the recalling firm.
The recalled product
- Product
- ALPRAZOLAM (ALPRAZOLAM)
- Brand
- ALPRAZOLAM
- Manufacturer
- Sandoz Incorporated
- Category
- Drug — Prescription Medication
- Affected units
- 1,332
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot EJ9591
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ALPRAZOLAM
- HighAlprazolam XR Extended-Release Tablets Recalled Due to Dissolution Failure
FDA (Drugs) · 2022-05-11
- HighNeolpharma Recalls Subpotent Alprazolam Tablets Nationwide
FDA (Drugs) · 2014-12-31
- ModerateActavis Recalls Alprazolam 1 mg Tablets Due to Significant Tablet Erosion
FDA (Drugs) · 2014-03-19
- SevereActavis Recalls Alprazolam Tablets Due to Weight Specification Failures
FDA (Drugs) · 2013-12-04
Same manufacturer · Sandoz Incorporated
See all →- ModerateSandoz Recalls Triamterene and Hydrochlorothiazide Tablets Due to Cross-Contamination
FDA (Drugs) · 2018-04-25
- ModerateSandoz Recalls Amitriptyline Hydrochloride Tablets Due to Cross-Contamination
FDA (Drugs) · 2017-07-12
- ModerateSandoz Recalls Nadolol Tablets Due to Failed Dissolution Test
FDA (Drugs) · 2017-01-04
- LowSandoz Recalls Fluoxetine Capsules Due to Illegible Logo
FDA (Drugs) · 2014-12-17
- SevereSandoz Recalls Tacrolimus Capsules Due to Fluvastatin Cross-Contamination
FDA (Drugs) · 2014-01-01
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01